Ad is loading...
AMLX
Price
$5.32
Change
+$0.13 (+2.50%)
Updated
Nov 22, 03:15 PM (EDT)
124 days until earnings call
PYPD
Price
$3.54
Change
+$0.12 (+3.50%)
Updated
Nov 22, 01:46 PM (EDT)
75 days until earnings call
Ad is loading...

AMLX vs PYPD

Header iconAMLX vs PYPD Comparison
Open Charts AMLX vs PYPDBanner chart's image
Amylyx Pharmaceuticals
Price$5.32
Change+$0.13 (+2.50%)
Volume$2.59K
CapitalizationN/A
PolyPid
Price$3.54
Change+$0.12 (+3.50%)
Volume$100
CapitalizationN/A
AMLX vs PYPD Comparison Chart
Loading...
AMLX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
AMLX vs. PYPD commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a Hold and PYPD is a Hold.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (AMLX: $5.19 vs. PYPD: $3.43)
Brand notoriety: AMLX and PYPD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMLX: 114% vs. PYPD: 60%
Market capitalization -- AMLX: $355.76M vs. PYPD: $23.74M
AMLX [@Biotechnology] is valued at $355.76M. PYPD’s [@Biotechnology] market capitalization is $23.74M. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 0 FA rating(s) are green whilePYPD’s FA Score has 0 green FA rating(s).

  • AMLX’s FA Score: 0 green, 5 red.
  • PYPD’s FA Score: 0 green, 5 red.
According to our system of comparison, AMLX is a better buy in the long-term than PYPD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 3 TA indicator(s) are bullish.

  • AMLX’s TA Score: 3 bullish, 5 bearish.

Price Growth

AMLX (@Biotechnology) experienced а +3.39% price change this week, while PYPD (@Biotechnology) price change was +0.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.14%. For the same industry, the average monthly price growth was -4.98%, and the average quarterly price growth was +4.01%.

Reported Earning Dates

AMLX is expected to report earnings on Mar 26, 2025.

PYPD is expected to report earnings on Feb 05, 2025.

Industries' Descriptions

@Biotechnology (+2.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMLX($356M) has a higher market cap than PYPD($23.7M). PYPD YTD gains are higher at: -9.737 vs. AMLX (-64.742). PYPD has higher annual earnings (EBITDA): -25.12M vs. AMLX (-212.04M). AMLX has more cash in the bank: 234M vs. PYPD (9.53M). AMLX has less debt than PYPD: AMLX (2.57M) vs PYPD (10M). AMLX has higher revenues than PYPD: AMLX (196M) vs PYPD (0).
AMLXPYPDAMLX / PYPD
Capitalization356M23.7M1,502%
EBITDA-212.04M-25.12M844%
Gain YTD-64.742-9.737665%
P/E Ratio2.69N/A-
Revenue196M0-
Total Cash234M9.53M2,455%
Total Debt2.57M10M26%
TECHNICAL ANALYSIS
Technical Analysis
AMLX
RSI
ODDS (%)
Bearish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 12 days ago
75%
Declines
ODDS (%)
Bearish Trend 8 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
AMLX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYRAX47.910.35
+0.74%
Rydex Retailing H
JHLVX61.970.40
+0.65%
JHancock Fundamental Large Cap Core C
FIVPX10.530.01
+0.10%
Fidelity Advisor International Value M
AMGOX21.14N/A
N/A
Alger Mid Cap Growth I-2
QTERX10.86-0.03
-0.28%
AQR Emerging Multi-Style II R6

AMLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been loosely correlated with ATRA. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if AMLX jumps, then ATRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
-0.76%
ATRA - AMLX
55%
Loosely correlated
-0.66%
IKNA - AMLX
54%
Loosely correlated
+1.76%
JAZZ - AMLX
43%
Loosely correlated
+4.91%
VNDA - AMLX
42%
Loosely correlated
+0.82%
NTLA - AMLX
41%
Loosely correlated
+5.18%
More

PYPD and

Correlation & Price change

A.I.dvisor indicates that over the last year, PYPD has been loosely correlated with VTYX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if PYPD jumps, then VTYX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYPD
1D Price
Change %
PYPD100%
-1.72%
VTYX - PYPD
37%
Loosely correlated
+0.58%
LBPH - PYPD
32%
Poorly correlated
N/A
AMLX - PYPD
29%
Poorly correlated
-0.76%
INM - PYPD
28%
Poorly correlated
+9.93%
VRAX - PYPD
28%
Poorly correlated
+3.19%
More